APPLICATION OF A BIOASSAY WITH CHO CELLS FOR THE ROUTINE DETECTION OFSTIMULATING AND BLOCKING AUTOANTIBODIES TO THE TSH-RECEPTOR

Citation
Ng. Morgenthaler et al., APPLICATION OF A BIOASSAY WITH CHO CELLS FOR THE ROUTINE DETECTION OFSTIMULATING AND BLOCKING AUTOANTIBODIES TO THE TSH-RECEPTOR, Hormone and Metabolic Research, 30(3), 1998, pp. 162-168
Citations number
32
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
00185043
Volume
30
Issue
3
Year of publication
1998
Pages
162 - 168
Database
ISI
SICI code
0018-5043(1998)30:3<162:AOABWC>2.0.ZU;2-J
Abstract
The importance of bioassays measuring stimulating and blocking autoant ibodies to the TSH-receptor (TSH-R) by their effect on CAMP production in CHO cells transfected with the recombinant TSH-R is increasingly r ecognized. The standard technique for this bioassay is cumbersome, as it involves purification of serum IgG with polyethylene glycol (PEG) a nd resuspension in hypotonic buffer. We have therefore established a s impler approach for the detection of stimulating and blocking autoanti bodies using JP09 CHO cells and unfractionated human serum. The cAMP c oncentration was measured by a highly sensitive commercial radioimmuno assay. Thyroid stimulating autoantibodies (TSAb) were present in 107 out of 126 patients with Graves' disease (85%) and in 4 out of 40 pati ents with Hashimoto's thyroiditis (10%). Specificity was confirmed by the fact that only 1 patient with insulin dependent diabetes mellitus (IDDM) out of 64 patients with different non-thyroid autoimmune disord ers (46 with IDDM, 10 with stiff man syndrome and 8 with rheumatoid ar thrites) and 2 out of 100 healthy controls (2%) were positive in this assay. In the subgroup of hyperthyroid Graves' disease patients 76 out of 83 (92%) had TSAb and the same number had TSH binding inhibiting i mmunoglobulin (TBII), as assessed by the commercial TRAK assay. Althou gh both antibody types showed only a weak correlation (r = 0.30), a co mbination of TSAb and TBII detected 98% of all Graves' patients and 99 % of the hyperthyroid subgroup. Thyroid blocking autoantibodies (TBAb) were measured in 4 out of 24 TSAb negative patients with Graves' dise ase (17%), who were hypothyroid and positive for TBII. A comparison of our bioassay with the standard bioassay using PEG precipitation showe d a good correlation (r = 0.76, p < 0.001), demonstrating the feasibil ity of the simplified assay for the routine detection of TSAb and TBAb in Graves' disease.